Loading candles…
Themis Medicare Ltd., incorporated in 1969, operates in the pharmaceutical industry, focusing on the development and manufacture of high-value finished pharmaceutical formulations and synthetic Active Pharmaceutical Ingredients (APIs). Employing a vertically integrated model, the company manages activities from research and development through to production. It serves both the domestic Indian market and exports to 44 countries. The business encompasses two main segments: Hospital Business and exports. Themis Medicare is expanding its Hospital Business in India, targeting critical and intensive care segments. Its product portfolio includes formulation pharmaceutical products and API pharmaceutical products.
| To consider and approve the financial results for the period ended Jun 30, 2025 |
| 1 Aug 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 and dividend | 20 May 2025 |
Besseggen InfoTech LLP is a SEBI-registered stock broker (Reg. No. INZ000213450), member of NSE (90155 (Cash & F&O)) and BSE (6722 (Cash & F&O)). Investment in securities market are subject to market risks; read all related documents carefully before investing.